Recherche
-
Oligonucleotide solid nucleolipid nanoparticles against antibiotic resistance of ESBL-producing bacteria
(Pharmaceutics. vol. 14, n° 2, pp. 299, 2022)Article de revue -
Targeting the Nucleosome Acidic Patch by Viral Proteins: Two Birds with One Stone?
(mBio. vol. 13, n° 2, 2022-04-26)Article de revueLibre accès -
The Antibacterial Type VII Secretion System of Bacillus subtilis: Structure and Interactions of the Pseudokinase YukC/EssB
(mBio. pp. e0013422, 2022-09-28)Article de revueLibre accès -
Deciphering RNA G-quadruplex function during the early steps of HIV-1 infection
(Nucleic Acids Research. vol. 50, n° 21, pp. 12328-12343, 2022)Article de revueLibre accès -
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration
(Journal of Virology. vol. 96, 2022-06-27)Article de revueLibre accès -
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
(Clinical Microbiology and Infection. vol. 28, n° 7, pp. 1010-1016, 2022-07-01)Article de revueLibre accès -
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces
(Antimicrobial Agents and Chemotherapy. vol. 66, n° 8, 2022)Article de revueLibre accès -
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020
(Eurosurveillance. vol. 27, n° 6, pp. 2100406, 2022)Article de revueLibre accès -
Identification of new components of the basal pole of Toxoplasma gondii provides novel insights into its molecular organization and functions
(Frontiers in Cellular and Infection Microbiology. vol. 12, 2022-10-13)Article de revueLibre accès -
Sotrovimab to Prevent Severe COVID-19 in High-Risk Patients Infected with Omicron BA.2
(Journal of Infection. vol. 85, n° 4, pp. E104-E108, 2022)Article de revueLibre accès